Monitoring of anti-drug antibodies and disease-specific biomarkers in three patients from a Japanese Fabry family treated with enzyme replacement therapy.

Kubota, Takao; Tsukimura, Takahiro; Shiga, Tomoko; Togawa, Tadayasu; Sakuraba, Hitoshi

Kubota, Takao; Tsukimura, Takahiro; Shiga, Tomoko; Togawa, Tadayasu; Sakuraba, Hitoshi.

Afiliação

Kubota T; Department of Nephrology, Tohto Sangenjaya Clinic, 2-13-2 Taishido, Setagaya, Tokyo, 154-0004, Japan.
Tsukimura T; Department of Nephrology, Self-Defence Forces Central Hospital, 1-2-24 Ikejiri, Setagaya, Tokyo, 154-8532, Japan.
Shiga T; Department of Functional Bioanalysis, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo, 204-8588, Japan.
Togawa T; Department of Clinical Genetics, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo, 204-8588, Japan.
Sakuraba H; Department of Functional Bioanalysis, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo, 204-8588, Japan.

CEN Case Rep ; 12(2): 171-175, 2023 05.

Article em En | MEDLINE | ID: mdl-36205882

Assuntos

Doença de Fabry; Humanos; Masculino; Feminino; Doença de Fabry/genética; Terapia de Reposição de Enzimas; População do Leste Asiático; Biomarcadores

Palavras-chave

Anti-drug antibody; Biomarker; Enzyme replacement therapy; Fabry disease; Globotriaosylceramide; Globotriaosylsphingosine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Fabry Limite: Female / Humans / Male Idioma: En Revista: CEN Case Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google